Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Antimicrobial Agents and Chemotherapy|September 1, 1986
Dose ranging study and constant infusion evaluation of ciprofloxacinG L Drusano, K I Plaisance, A Forrest, et al.
Clinical Pharmacology and Therapeutics|June 1, 1989
A prospective evaluation of optimal sampling theory in the determination of the steady-state pharmacokinetics of piperacillin in febrile neutropenic cancer patientsG L Drusano, A Forrest, K I Plaisance, et al.
Pharmaceutical Research|January 1, 1991
Absorption and disposition of colloidal drug delivery systems. I. High-performance liquid chromatographic (HPLC) analysis of a cyclosporin emulsionS J Corvari, R G Hollenbeck, J Leslie, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1987
Effect of dose size on bioavailability of ciprofloxacinK I Plaisance, G L Drusano, A Forrest, et al.
Pharmacotherapy|December 29, 2000
Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infectionsK I Plaisance, S Kudaravalli, S S Wasserman, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1989
Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphateK I Plaisance, G L Drusano, A Forrest, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1990
Effect of renal function on the bioavailability of ciprofloxacinK I Plaisance, G L Drusano, A Forrest, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1988
Relationships between renal function and disposition of oral ciprofloxacinA Forrest, M Weir, K I Plaisance, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1987
Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patientsG L Drusano, K I Plaisance, A Forrest, et al.
Neurology|June 1, 1994
The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trialC T Bever, D Young, P A Anderson, et al.
Pageof 2